Primary Tumor Resection Decelerates Disease Progression in an Orthotopic Mouse Model of Metastatic Prostate Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.3390/cancers14030737
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2022
- Urheber
-
Linxweiler, Johannes
Hajili, Turkan
Zeuschner, Philip
Menger, Michael D.
Stöckle, Michael
Junker, Kerstin
Saar, Matthias
- DOI
-
10.18154/RWTH-CONV-250239
- URN
-
urn:nbn:de:101:1-2023012900395726410027
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:41 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Linxweiler, Johannes
- Hajili, Turkan
- Zeuschner, Philip
- Menger, Michael D.
- Stöckle, Michael
- Junker, Kerstin
- Saar, Matthias
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2022
Ähnliche Objekte (12)
CCR5 status and metastatic progression in colorectal cancer
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
Angio-regulation of liver neovascularization and lung metastatic progression
Metabolic changes during prostate cancer development and progression
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups
Effect of chemotherapy on overall survival in contemporary metastatic prostate cancer patients
Diabetes and beta adrenergic blockage are risk factors for metastatic prostate cancer
Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer
Regulation of S100A8 and S100A9 expression in prostate cancer and impact for prostate cancer progression
Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo
Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer
Mechanistic analysis and preclinical validation of novel combination therapies targeting metastatic progression
CCR5 status and metastatic progression in colorectal cancer
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
Angio-regulation of liver neovascularization and lung metastatic progression
Metabolic changes during prostate cancer development and progression
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups
Effect of chemotherapy on overall survival in contemporary metastatic prostate cancer patients
Diabetes and beta adrenergic blockage are risk factors for metastatic prostate cancer
Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer
Regulation of S100A8 and S100A9 expression in prostate cancer and impact for prostate cancer progression
Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo
Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer
Mechanistic analysis and preclinical validation of novel combination therapies targeting metastatic progression
CCR5 status and metastatic progression in colorectal cancer
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
Angio-regulation of liver neovascularization and lung metastatic progression
Metabolic changes during prostate cancer development and progression
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups
Effect of chemotherapy on overall survival in contemporary metastatic prostate cancer patients
Diabetes and beta adrenergic blockage are risk factors for metastatic prostate cancer
Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer
Regulation of S100A8 and S100A9 expression in prostate cancer and impact for prostate cancer progression
Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo
Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer